Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Integrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.

Negroni L, Taouji S, Arma D, Pallares-Lupon N, Leong K, Beausang LA, Latterich M, Bossé R, Balabaud C, Schmitter JM, Bioulac-Sage P, Zucman-Rossi J, Rosenbaum J, Chevet E.

Mol Cell Proteomics. 2014 Dec;13(12):3473-83. doi: 10.1074/mcp.M114.043174. Epub 2014 Sep 15.

2.

A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitor.

Bidaud-Meynard A, Arma D, Taouji S, Laguerre M, Dessolin J, Rosenbaum J, Chevet E, Moreau V.

Biochem J. 2013 Feb 15;450(1):55-62. doi: 10.1042/BJ20120572.

PMID:
23181668
3.

Sorafenib-mediated targeting of the AAA⁺ ATPase p97/VCP leads to disruption of the secretory pathway, endoplasmic reticulum stress, and hepatocellular cancer cell death.

Yi P, Higa A, Taouji S, Bexiga MG, Marza E, Arma D, Castain C, Le Bail B, Simpson JC, Rosenbaum J, Balabaud C, Bioulac-Sage P, Blanc JF, Chevet E.

Mol Cancer Ther. 2012 Dec;11(12):2610-20. doi: 10.1158/1535-7163.MCT-12-0516. Epub 2012 Oct 5.

Supplemental Content

Support Center